Načítá se...
Evaluation of Oritavancin Use at a Community Hospital
Background: Oritavancin is a lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and soft tissue infections. The prolonged half-life of this agent allows for a course of therapy to be completed with a single dose. Oritavancin was added to our formulary as an option for tr...
Uloženo v:
| Vydáno v: | Hosp Pharm |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050883/ https://ncbi.nlm.nih.gov/pubmed/30038448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717746415 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|